Business
Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations
Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations.
About this update from Amarantus Bioscience Holdings, Inc.
[{"type":"text","content":"\n NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has appointed Marsha Fontanive as Vice President of Sales, and Chris Gross as Vice President of Sales Operations. Collectively, Ms. Fontanive and Mr. Gross bring more than 40 years of life sciences sales and sales operations experience to Todos. They will be working to significantly increase Todos’ national sales capabilities by delivering a 25-person salesforce of seasoned laboratory sales representatives to market Todos’ unique combination of COVID-19 testing equipment, reagents and supplies to national and international markets. “Todos has quietly built a tremendous portfolio of products that are sorely needed in the CLIA laboratory marketplace to increase the capacity for COVID-19 testing in the United States,” said Marsha Fontanive, Vice President of Sales at Todos. “As the incoming team, we are well positioned to compete with more well-established competitors who are unable to meet the intense market need for full solutions that allow for rapid expansion of molecular testing capacity in the United States.” “We are excited with the COVID solutions Todos is putting together,” said Chris Gross, VP of Sales Operations at Todos. “At a time when we expect tremendous growth in Todos’ sales, we are focused on helping the sales operations scale to meet the significant pressure we expect in the months ahead. With proprietary testing solutions that address PCR, antigen and antibody testing, as well as Todos’ innovative 3C protease fluorescence assays that it will begin to bring to market that really fill in the potential life cycle of COVID-19 testing, we see tremendous potential to capture market share for Todos.” Ms. Fontanive, MS is the incoming Vice President of Sales at Todos. She currently is President of Expansion Medical Consulting, a consulting company she founded in 2010. Ms. Fontanive has previously been in National and Regional Sales Manager roles for Glaxo, Genentech, Alza, T...